Document 0469
 DOCN  M9490469
 TI    Inhibitors of HIV-1 transcription.
 DT    9411
 AU    Li CJ; Dezube BJ; Biswas DK; Ahlers CM; Pardee AB; Divn of Cell Growth
       and Regulation, Dana-Farber Cancer Institute,; Boston, MA 02115.
 SO    Trends Microbiol. 1994 May;2(5):164-9. Unique Identifier : AIDSLINE
       MED/94332441
 AB    No curative drug against HIV has yet been found, despite enormous
       efforts aimed at reverse transcriptase and a variety of other targets.
       The long terminal repeat (LTR) of HIV-1 has recently become a promising
       site for antiviral action. This article briefly summarizes information
       on the nature of this target and potential anti-LTR expression drugs.
 DE    Acquired Immunodeficiency Syndrome/*DRUG THERAPY  Antiviral
       Agents/*PHARMACOLOGY/THERAPEUTIC USE  Base Sequence  Human  HIV Long
       Terminal Repeat/*GENETICS  HIV-1/*DRUG EFFECTS/GENETICS  Models,
       Biological  Molecular Sequence Data  Support, Non-U.S. Gov't  Support,
       U.S. Gov't, P.H.S.  Trans-Activation (Genetics)/DRUG EFFECTS
       Transcription, Genetic/*DRUG EFFECTS  JOURNAL ARTICLE  REVIEW  REVIEW,
       TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).